Contrarian Corpus
short seller research note initial thesis
2019-06-27 · 29 pages

New Age Beverage Corp. NBEV

NBEV paid $85m for Morinda, an MLM with inflated China financials and missing licenses in 60% of provinces — stock faces 60% immediate downside.

N 4 Narrative
V 2 Visual
C 2 Craft
Unlock to download PDF Grizzly Research ↗

Thesis

NBEV's December 2018 merger with Morinda for $85 million is a disaster disguised as a bargain: Grizzly's on-the-ground research shows Morinda's China revenue was inflated 51% in 2016 and 36% in 2017 versus SAIC filings, and that Morinda operates without direct-selling licenses in 60% of the Chinese provinces it serves. The report ties Morinda's primary product to the same Noni Juice brand exposed by CCTV in its January 2019 hit on NHTC — which saw shares collapse 60% — and notes China regulators have suspended new MLM license issuance. CEO Brent Willis, whose prior ventures XFit Brands and Electronic Cigarettes International collapsed, boasted about $46m of Morinda cash while omitting $50m in hidden contractual obligations. A tiny Florida auditor, accelerating insider sales, and reliance on dilutive equity raises to stay afloat point to immediate 60% downside and potential insolvency.

SCQA

Situation

New Age Beverage is a NASDAQ-listed beverage roll-up that acquired MLM firm Morinda for $85 million in December 2018, marketing the deal as a transformational bargain at under 0.5x Morinda's 2017 sales.

Complication

Morinda's China revenues are inflated versus SAIC filings (51% in 2016, 36% in 2017), it lacks direct-selling licenses in 60% of China provinces amid a nationwide MLM crackdown, and hides over $50m in contractual obligations to Morinda shareholders.

Resolution

Grizzly publishes its short thesis urging investors to sell NBEV, arguing the Morinda acquisition is fraudulent, the roll-up depends on dilutive equity raises, and a China regulatory action could wipe out Morinda's profit contribution overnight.

Reward

Immediate downside of 60% from the June 2019 price of $4.56, with scope to fall much lower — potentially insolvency — as Morinda's contribution collapses and continued equity issuance dilutes shareholders 30-88%.

The three reasons

  1. 1

    Morinda's China revenue inflated 51% in 2016 and 36% in 2017 versus SAIC filings

  2. 2

    Morinda lacks direct-selling licenses in 60% of Chinese provinces it operates in

  3. 3

    CEO Brent Willis previously ran XFIT and ECIGQ — both collapsed toward zero

Primary demands

  • Sell NBEV — immediate 60% downside with further insolvency risk
  • Scrutinize Morinda's overstated China financials and missing MLM licenses
  • Investigate CEO Brent Willis's track record and accelerating insider sales

KPIs cited

Morinda 2016 China revenue inflation
$68m reported vs. $33m in SAIC filings — ~51% overstatement
Morinda 2017 China revenue inflation
Overstated by ~36% vs. Chinese filings
Morinda 2017 China net loss
$32m net loss per Chinese financial filings
Hidden Morinda liabilities
>$50m in contractual obligations owed to Morinda shareholders, omitted on earnings call
NBEV 2018 net loss
$12m net loss; negative $21.8m operating cash flow
Morinda licensing gap
Operating illegally in 60% of Chinese provinces it serves
Tahitian Noni Juice concentration
90% of Morinda sales from a single product with no substantiated health benefits
Share count growth
More than doubled from ~35m to over 75m in 2018
Potential ATM dilution
29.5% at $4.50 up to 88.4% at $1.50 on $100m ATM offering
Marley CBD deal economics
NBEV pays 50% of revenue; industry standard is ~25%
Morinda.com web traffic
Daily sessions declined from ~900k peak to ~100k
Insider sale
CEO Brent Willis sold 300,000 shares for $1.6m in April 2019 — largest insider sale in years
Projected downside
60% from $4.56 June 26, 2019 price

Pattern membership

Where this document fits across the library's 12 rhetorical / structural patterns. Orange cells are present in this deck; neutral cells are not.

Precedents cited

  • NHTC CCTV expose January 2019 (shares -60%)
  • Quanjian Group MLM crackdown
  • Hualin Group MLM crackdown
  • Infinitus (China) MLM crackdown
  • Tianshi Group MLM crackdown
  • Deloitte Malaysia and Brazil audit fines

Composition what's on the 22 slides

Visual + textual elements counted across every slide in this deck. Hover a box for what that element is; click to see every slide in the corpus that uses it.

Chart types used in this deck

Slide gallery ·

All 22
No slide inventory yet

Pass-2 extraction may still be in progress for this deck.

Notes

Classic China-fraud short report built on on-the-ground fieldwork: photos of unlicensed Morinda offices, SAIC vs SEC financial reconciliation, and an analogy to the January 2019 CCTV/NHTC expose. Cover page reads 'Publication Date June 27th 2018' but filename and content (June 26 2019 price, June 2019 Marley deal, April 2019 Form 4) confirm this is a June 27, 2019 report — the cover '2018' is a typo. Document is Word-style prose with occasional photo collages and small tables; 'Not For Distribution' watermark across body pages. Author is the Grizzly Research team, no individual signatory on cover or closing.